Carnegie Investment Counsel’s Invacare Corporation IVC Stock Holding History

Carnegie Investment Counsel’s Portfolio IVC Stock Details IVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$4.2K	–	528
2022 Q4	$4.2K	Hold	10,000	–	–	﹤0.01%	510
2022 Q3	$8K	Buy	+10,000	New	+$10.5K	﹤0.01%	473

Other funds holding IVC

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Carnegie Investment Counsel's IVC Position: Q1 2023 in Review

Carnegie Investment Counsel sold out of Invacare Corporation (IVC) in Q1 2023, closing a stake of 10,000 shares — an estimated $4.2K sold.

Carnegie Investment Counsel first reported a position in IVC in Q3 2022 and held it in 2 quarters. The position peaked at $8K in Q3 2022. 10 funds tracked by Wall St. Rank hold IVC as of Q1 2023.

Carnegie Investment Counsel reported no remaining Invacare Corporation position as of Q1 2023 after selling out during the quarter.
Carnegie Investment Counsel sold 10,000 Invacare Corporation shares in Q1 2023, an estimated $4.2K.
Carnegie Investment Counsel first reported a position in Invacare Corporation in Q3 2022 and held it in 2 quarters.
Carnegie Investment Counsel's Invacare Corporation position peaked at $8K in Q3 2022.
10 funds tracked by Wall St. Rank held Invacare Corporation as of Q1 2023.

Based on Carnegie Investment Counsel's 13F filing for Q1 2023, filed 20 Apr 2023.